Filter This View

  • June 8, 2009 |

    Cleary, Shearman confirm jobs for September NQs

    Cleary Gottlieb Steen & Hamilton is to keep on all six of its September 2009 qualifying trainees in the City while Shearman & Sterling has offered jobs to nearly two thirds of its qualifiers. Cleary has continued its record of retaining every qualifying trainee since it introduced its trainee programme in the City in 1997. One trainee will focus on tax while the remainder will keep a broader corporate practice.

    1 minute read

  • June 3, 2009 |

    Shearman in top gear on GM's Hummer sell-off

    Shearman & Sterling has won a lead role on the acquisition of General Motors' Hummer brand by a Chinese industrial manufacturer. Shearman advised China's Sichuan Tengzhong Heavy Industrial Machinery (Tengzhong) on its purchase, in a deal reportedly worth up to $250m (£151m).

    1 minute read

  • June 2, 2009 |

    Shearman leads on €3bn Danone rights issue

    Shearman & Sterling and Bredin Prat have taken lead roles on French dairy and water company Danone's €3bn (£2.6bn) rights issue. The company, whose flagship products include Evian, Activia and Actimel, launched a public offering in France and Switzerland yesterday (1 June) accompanied by an international private placement in a bid to reduce its debt.

    1 minute read

  • June 2, 2009 |

    Bingham seals City tax launch with McDermott hire

    Bingham McCutchen has launched a London tax practice with the hire of a partner from US rival McDermott Will & Emery. Stuart Sinclair joined Bingham today (1 June), becoming the firm's first tax partner in the City.

    1 minute read

  • May 29, 2009 |

    International firms win roles on GM restructuring

    The collapse of automotive giant General Motors has handed roles to at least 15 law firms so far in one of the largest restructurings to date.

    1 minute read

  • May 22, 2009 |

    Shearman takes lead on $1.2bn Novartis buyout

    Shearman & Sterling has advised longtime client Novartis on its $1.2bn (£757m) acquisition of the generic cancer drug business of EBEWE Pharma, reports The Am Law Daily. Corporate partner Harald Selzner, who is based in Duesseldorf, led the firm's team on the deal.Shearman has represented Swiss-based pharma giant Novartis on several previous deals, including its $8.4bn (£5.3bn) acquisition of generic drug makers Eon Labs and Hexal in 2005. Wachtell Lipton Rosen & Katz also advised Novartis on that deal.

    1 minute read

  • May 13, 2009 |

    Norton Rose acts on Greece's first consumer finance securitisation deal

    Norton Rose has advised on the closing of the first consumer finance securitisation in Greece. The firm fielded a team from its London headquarters led by capital markets partner Sandrine Sauvel.The loans, originating from Piraeus Bank, are the first consumer finance loans securitised in Greece to be covered by a major credit rating agency. The transaction, arranged by Morgan Stanley, involved €493m (£435m) in class A notes, which were rated by Moody's, and €232m (£208m) in class B notes.

    1 minute read

  • May 7, 2009 |

    US law firms face worst year for PEP since 1991

    America's legal elite has emerged from its worst financial year since 1991 as partner profits and lawyer productivity at the US's top 100 law firms fell for the first time in 17 years.Eagerly-awaited 2008 results from Legal Week's sister title The American Lawyer confirms the dramatic impact of a fourth quarter dominated by financial turmoil, leading to an immediate global slump in demand for legal services.

    1 minute read

  • May 1, 2009 |

    Linklaters hires White & Case partner in New York

    Linklaters has secured its second US partner hire in less than a month, with the magic circle firm recruiting corporate partner Daniel Dufner from White & Case in New York. Dufner has been a partner at White & Case since 2004 and has represented a range of clients on both public and private M&A matters. The hire takes the number of partners in Linklaters New York corporate practice to seven.Dufner's recent deals include advising pharmacy management company,Express Scripts on its $4.7bn (£3.1bn) acquisition of WellPoint's pharmacy benefit management business and the spin-off of EchoStar from a satellite TV, equipment sales and support company, DISH Network.

    1 minute read

  • April 8, 2009 |

    Shearman acts for Dow Chemical on $1.7bn sale

    Shearman & Sterling has reprised its role for Dow Chemical, advising the company as it agrees to sell Rohm and Haas unit Morton International to a German agrichemicals company for $1.7bn (£1.14bn). The company will use the sale to help finance its $16.5bn (£11.1bn) buyout of Rohm, which closed last week (2 April) - a deal on which it also turned to Shearman.

    1 minute read